Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Racial Disparities in the Care of Patients with Type 1 Diabetes: Results from a Multicenter Study in Brazil.

Journal of racial and ethnic health disparities·2026
Same author

Genomic ancestry and diversity in individuals with type 1 diabetes from Brazil and Portugal: a descriptive analysis.

Diabetology & metabolic syndrome·2026
Same author

Correction: Type 1 diabetes in Brazil: a narrative overview of the Brazilian Type 1 Diabetes Study Group.

Diabetology & metabolic syndrome·2025
Same author

Influence of Genomic Ancestry and Other Traditional Risk Factors on the Prevalence of Diabetic Peripheral Neuropathy in Admixed Individuals With Type 1 Diabetes in Brazil: A Pioneer Multicenter Study.

Journal of the peripheral nervous system : JPNS·2025
Same author

Exploring the mitochondrial DNA ancestry of patients with type 1 diabetes from an admixed population of the Northeast of Brazil.

Scientific reports·2025
Same author

Type 1 diabetes in Brazil: a narrative overview of the Brazilian Type 1 Diabetes Study Group.

Diabetology & metabolic syndrome·2025

Related Experiment Videos

[Type 1 diabetic patients evolution to hypertension].

Roberta Cobas1, Bráulio Santos, Luiza Braga

  • 1Faculdade de Ciências Médicas, Universidade Estadual do Rio de Janeiro, RJ, Brasil. robertacobas@ig.com.br

Arquivos Brasileiros De Endocrinologia E Metabologia
|July 8, 2008
PubMed
Summary

Type 1 diabetes patients often develop high blood pressure (hypertension). Monitoring renal function and blood pressure is crucial for preventing complications like nephropathy and cardiovascular disease.

Related Experiment Videos

Area of Science:

  • Endocrinology
  • Nephrology
  • Cardiology

Context:

  • Type 1 diabetes (T1D) is a chronic condition requiring lifelong management.
  • Hypertension is a common and serious complication in T1D patients.
  • Early detection and management of blood pressure are vital for T1D outcomes.

Purpose:

  • To investigate the progression of T1D patients to prehypertension and hypertension.
  • To identify baseline factors associated with final blood pressure levels in T1D.
  • To assess the impact of prehypertension on the development of hypertension.

Summary:

  • Observational study followed 127 T1D patients for 5 years.
  • Prevalence of prehypertension and hypertension increased significantly.
  • Serum creatinine levels predicted final systolic and diastolic blood pressure.

Impact:

  • Highlights the importance of regular renal function and blood pressure monitoring in T1D.
  • Emphasizes proactive management to mitigate risks of nephropathy and cardiovascular disease.
  • Suggests early intervention for elevated blood pressure in T1D patients.